City Center Advisors LLC’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$202K Buy
+7,081
New +$188K 0.15% 184
2026
Q2
– Sell
-7,460
Closed -$209K – 182
2026
Q1
$209K Sell
7,460
-5,265
-41% -$140K 0.19% 152
2025
Q4
$317K Buy
+12,725
New +$321K 0.29% 106
2024
Q3
– Sell
-8,054
Closed -$224K – 192
2024
Q2
$224K Hold
8,054
– – 0.26% 145
2024
Q1
$224K Buy
+8,054
New +$223K 0.26% 145

Other funds holding PFE

City Center Advisors LLC's PFE Position: Q3 2026 in Review

City Center Advisors LLC opened a new position in Pfizer (PFE) in Q3 2026: 7,081 shares worth $202K. The stake represents 0.15% of the portfolio and ranks #184 among its holdings. This is a return to the name: City Center Advisors LLC previously reported a position in PFE as recently as Q1 2026.

City Center Advisors LLC first reported a position in PFE in Q1 2024 and has held it in 5 quarters since. The position peaked at $317K in Q4 2025. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • City Center Advisors LLC held 7,081 shares of Pfizer worth $202K as of Q3 2026.
  • Pfizer was a new City Center Advisors LLC position in Q3 2026.
  • Pfizer made up 0.15% of City Center Advisors LLC's portfolio in Q3 2026, its #184 holding.
  • City Center Advisors LLC first reported a position in Pfizer in Q1 2024 and has held it in 5 quarters since.
  • City Center Advisors LLC's Pfizer position peaked at $317K in Q4 2025.
  • 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on City Center Advisors LLC's 13F filing for Q3 2026, filed 8 Oct 2026.